SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-028135
Filing Date
2021-02-04
Accepted
2021-02-04 08:10:31
Documents
14
Period of Report
2021-02-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d132423d8k.htm   iXBRL 8-K 27507
2 EX-99.1 d132423dex991.htm EX-99.1 10876
6 GRAPHIC g132423g0202183024893.jpg GRAPHIC 3489
  Complete submission text file 0001193125-21-028135.txt   175044

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tcrr-20210203.xsd EX-101.SCH 3056
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrr-20210203_lab.xml EX-101.LAB 18886
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrr-20210203_pre.xml EX-101.PRE 11850
7 EXTRACTED XBRL INSTANCE DOCUMENT d132423d8k_htm.xml XML 3445
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38811 | Film No.: 21588917
SIC: 2836 Biological Products, (No Diagnostic Substances)